Global Rubella Testing Market 2016-2024 - Future Horizons and Growth Strategies
Rubella
Testing Market: Overview
Rubella or German measles
is a serious condition (disease) caused by the infection of rubivirus (genus).
Sometimes rubella when passed from pregnant mother to her baby then it is
termed as congenital rubella. Rubella is a contagious disease and can spread
through air or close contact between patient and a healthy individual. Signs
and symptom of rubella include fever, headache, inflammation of the eyes and
muscle or joint pain.
Browse
Full Report : http://www.transparencymarketresearch.com/rubella-diagnostic-testing-market.html
Culture test (nasal or
throat swab culture) and blood test to check the function of immune system are
the major tests performed for the detection of rubella. Women who are pregnant
must undergo rubella test to know the functioning of immune system against
rubella virus. There remains chance of miscarriage or stillbirth for those pregnant
mothers who are suffering from measles as the child may be born with birth
defects.
Presently there is no
treatment option available in the market for the treatment of rubella. Patients
are prescribed acetaminophen for reduction of rubella fever. Rubella can be
prevented with the utilization of measles-mumps-rubella (MMR) vaccine. Rubella
vaccine is recommended for all children and is routinely given when children
are 12 months to 15 months old. Almost everyone who receives the vaccine has
immunity to rubella for his lifetime.
Rubella
Testing Market: Segmentation
The
global market for rubella testing can be segmented as:
·
By
Application
o Hospitals
o Commercial/Private labs
o Physician offices
o Public health labs
Rubella Testing Market: Drivers
The global market for
rubella testing is being driven primarily due to increasing awareness among
people and advancement in diagnostic test. Moreover, government initiatives and
support also accounted for the growth of the global rubella testing market. Pregnant
mother who are suffering from rubella and are unaware about the high risk of
passing the disease from her to unborn baby also contributes significantly in
the market growth.
Centre for Disease Control
and Prevention (CDC) stated that more than 100,000 infants are born with
congenital rubella syndrome (CRS) annually worldwide. World Health Organization
(WHO) revealed that in 1996, the number of countries that have incorporated
rubella-containing vaccines into their routine national immunization program
was 83. Later in 2011, the number was increased to 130 for the incorporation of
rubella-containing vaccines into their routine national immunization.
Rubella Testing Market: Region-wise Outlook
North America dominates
the global market for rubella testing due to strong demand of diagnostic test
in this region. Moreover increasing awareness among people and initiative taken
by the federal government also accounted for the market growth in North
American region. Europe represents the second position in the global rubella
testing market due to increasing awareness among people and extensive
government initiative taken by the European government. For an instance, in
October 2010, WHO Region of the America and Europe has established rubella
elimination and CRS prevention goals for the year 2010 and 2015.
Asia - Pacific is
considered as an untapped market due to lack of awareness among people about
rubella testing. Asian market growth will be fuelled by the presence of
untapped opportunities due to extensive increase in the healthcare
infrastructure and growing market penetration in this region.
Request
A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2935
Rubella
Testing Market: Key Players
Major market
players contributing in the global market share of rubella testing market
includes Abbott Laboratories, Inc., Becton, Dickinson and Company, Biomerica,
Inc., bioMerieux, Inc., Novartis Diagnostics, Johnson & Johnson
Diagnostics, Inc., Olympus Corporation, Qiagen N.V., Siemens AG, Thermo Fischer
Scientific, Inc., and Zenith Healthcare Ltd.
The report
offers a comprehensive evaluation of the market. It does so via in-depth
qualitative insights, historical data, and verifiable projections about market
size. The projections featured in the report have been derived using proven
research methodologies and assumptions. By doing so, the research report serves
as a repository of analysis and information for every facet of the market,
including but not limited to: Regional markets, technology, types, and
applications.
About
Us
Transparency
Market Research (TMR) is a global market intelligence company providing
business information reports and services. The company’s exclusive blend of
quantitative forecasting and trend analysis provides forward-looking insight
for thousands of decision makers. TMR’s experienced team of analysts,
researchers, and consultants use proprietary data sources and various tools and
techniques to gather and analyze information.
TMR’s data
repository is continuously updated and revised by a team of research experts so
that it always reflects the latest trends and information. With extensive
research and analysis capabilities, Transparency Market Research employs rigorous
primary and secondary research techniques to develop distinctive data sets and
research material for business reports.
Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â sales@transparencymarketresearch.com
Post Your Ad Here
Comments